Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Alpha-2C adrenergic receptor | ||
| Ligand | BDBM50203558 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_454217 (CHEMBL903400) | ||
| Ki | 0.800000±n/a nM | ||
| Citation |  Hagihara, K; Kashima, H; Iida, K; Enokizono, J; Uchida, S; Nonaka, H; Kurokawa, M; Shimada, J Novel 4-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)methylbenzofuran derivatives as selective alpha(2C)-adrenergic receptor antagonists. Bioorg Med Chem Lett17:1616-21 (2007) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Alpha-2C adrenergic receptor | |||
| Name: | Alpha-2C adrenergic receptor | ||
| Synonyms: | ADA2C_HUMAN | ADRA2C | ADRA2L2 | ADRA2RL2 | Adrenergic alpha2C | Adrenergic receptor | Adrenergic receptor alpha | Adrenergic, alpha-2C-, receptor | Alpha-2 adrenergic receptor subtype C4 | Alpha-2C adrenoceptor | Alpha-2C adrenoreceptor | adrenergic, alpha-2C-, receptor [Homo sapiens] | ||
| Type: | Enzyme | ||
| Mol. Mass.: | 49552.32 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P18825 | ||
| Residue: | 462 | ||
| Sequence: |
| ||
| BDBM50203558 | |||
| n/a | |||
| Name | BDBM50203558 | ||
| Synonyms: | 4-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-7-methoxy-N-(quinuclidin-3-yl)benzofuran-2-carboxamide | CHEMBL394218 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C29H35N3O5 | ||
| Mol. Mass. | 505.6053 | ||
| SMILES | COc1cc2CCN(Cc3ccc(OC)c4oc(cc34)C(=O)NC3CN4CCC3CC4)Cc2cc1OC |w:23.24,TEB:22:23:26.27:30.29,(16.31,-37.39,;14.97,-38.15,;13.64,-37.38,;12.31,-38.14,;10.99,-37.37,;9.65,-38.14,;8.33,-37.37,;8.32,-35.83,;6.99,-35.06,;6.99,-33.52,;5.66,-32.75,;5.66,-31.2,;6.99,-30.43,;6.98,-28.9,;5.64,-28.13,;8.32,-31.2,;9.8,-30.71,;10.72,-31.96,;9.81,-33.22,;8.33,-32.75,;12.26,-31.95,;13.03,-33.28,;13.02,-30.61,;14.56,-30.63,;15.38,-31.75,;16.42,-30.44,;17.92,-30.34,;17.02,-29.25,;15.54,-29.36,;14.82,-27.89,;15.74,-28.65,;9.66,-35.05,;10.99,-35.83,;12.32,-35.07,;13.64,-35.84,;14.98,-35.08,;16.31,-35.85,)| | ||
| Structure | 
| ||